Canadian CANNAINVESTOR Magazine July / August 2017 - Page 87


Raphael Mechoulam, PhD

Organic chemist and professor of Medicinal Chemistry at the Hebrew University of Jerusalem

In 1963 isolated cannabidiol (CBD)

First scientist to isolate tetrahydrocannabinol (THC)

Over 25 academic awards including the Rothschild Prize in Chemical Sciences and Physical Sciences in 2012

Michael E. Shannon, M.A., M.Sc., M.D.

Served in the Canadian Forces for 31 years, retiring at the rank of Commodore as Deputy Surgeon General for Canada

Directed a phase III clinical trial in Canada, the U.S. and Great Britain for an artificial blood substitute product

Senior Medical Advisor for the Canadian Public Health Agency on special assignment directing the rebuilding of the Emergency Medical Response Capacity for Canada, the largest emergency response exercise in the history of the country

Directly responsible for the first approved human clinical trial in North America examining the efficacy of O3 delivered via autohemotherapy in the treatment of AIDS.

Has served as the Senior Media Advisor to Medizone International since 2002, and appointed the President of the Canadian Foundation for Global Health in 2008